名稱 | EML4(E13)-ALK(E20) Translocation |
型號 | CBP20209D |
報價 | |
特點 | EML4(E13)-ALK(E20) Translocation |
產(chǎn)品搜索
相關文章
聯(lián)系我們
聯(lián)系人:蔣經(jīng)理
電話:4008750250
號碼:
手機:18066071954
地址:南京市棲霞區(qū)緯地路9號
Email: zhangxiangwen@cobioer.com
電話:4008750250
號碼:
手機:18066071954
地址:南京市棲霞區(qū)緯地路9號
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
基因檢測標準品 > Translocation > CBP20209DEML4(E13)-ALK(E20) Translocation
- 詳細內(nèi)容
EML4(E13)-ALK(E20) Translocation EML4(E13)-ALK(E20) Translocation
Introduction | |
Format | DNA |
Description | EML4-ALK results from the fusion of EML4 and ALK, resulting in constitutive kinase activity, transformation in cultured cells, and tumor formation in mouse models . EML4-ALK fusions have been associated with non-small cell lung cancer . |
Technical Data | |
Left Gene | EML4(E13) |
Left Breakpoint | chr2:425****6:+ |
Right Gene | ALK(E20) |
Right Breakpoint | chr2:294****4:- |
%AF | 50% |
Buffer | Tris-EDTA |
Product Information | |
Intended Use | Research Use Only |
Unit Size | 1ug |
Concentration | Download for COA |
Purity | Download for COA |
RNA electrophoresis | Download for COA |
Sanger sequencing | Download for COA |
Storage | 4℃ |
Expiry | 36 months from the date of manufacture |
" _ue_custom_node_="true">